Natural compound in Japanese, Chinese herbal medicines hits elusive target in cancer cellsJuly 12th, 2008 - 12:32 pm ICT by ANI
Washington, July 12 (ANI): A natural compound from magnolia cones, found in Japanese and Chinese herbal medicines, has the ability to block an elusive pathway for cancer growth in a collaborative study.
Dr. Jack Arbiser of Emory University School of Medicine joined forces with Dr. David Foster of Hunter College of the City University of New York to study how the compound honokiol works.
“Knowing more about how honokiol works will tell us what kinds of cancer to go after. We found that it is particularly potent against tumours with activated Ras,” says Arbiser, who is an associate professor of dermatology.
A research article in the journal Clinical Cancer Research says that Ras refers to a family of genes whose mutation stimulates the growth of several types of cancers.
It further states that the Ras family, though mutated in around a third of human cancers, is considered by medicinal chemists to be an intractable target.
In their study report, the researchers write that honokiol’’s properties may make it useful in combination with other anti-tumour drugs, as blocking Ras activation may prevent tumours from escaping the effects of the medications.
“Honokiol could be effective as a way to make tumors more sensitive to traditional chemotherapy,” Arbiser says.
The researchers say that one of the effects of Ras is to drive pumps that remove chemotherapy drugs from cancer cells.
They have found that, in breast cancer cell lines, honoliol may prevent Ras from turning on an enzyme called phospholipase D, which allows cancer cells to stay alive when ordinary cells would die.
According to them, this compound seems to have similar effects in lung and bladder cancer cells in the laboratory.
Emory University is in the process of licensing honokiol and related compounds so that they can be tested in people in co-operation with industry partners. (ANI)
- Potent anticancer drug isolated from weed - Jul 10, 2012
- New way of treating lung cancer soon - Oct 11, 2011
- New hope for cancer cure - Jul 08, 2011
- New drugs to kill cancers minus side-effects - May 21, 2012
- Scientists identify four anti-cancer compounds - Nov 30, 2011
- Indian-origin scientist's finding offers hope for advanced cancer patients - Apr 06, 2011
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- Wonder drug could kill all types of cancer - Jun 27, 2011
- New aspirin curbs 11 kinds of cancer, shrinks tumours - Mar 09, 2012
- Inflammation drug promising in depression - Sep 04, 2012
- Strawberry extract protects skin against UV rays - Aug 05, 2012
- Arthritis drug could help treat skin cancer - Mar 24, 2011
- Breakthrough can reduce heart failure in cancer patients - Feb 10, 2011
- Arsenic could be a potential cancer treatment - Jul 13, 2010
- Electric shocks soften up cancer cells for treatment - Dec 07, 2010
Tags: bladder cancer, breast cancer, cancer cell, cancer cells, cancer growth, chemotherapy drugs, chinese herbal medicines, clinical cancer research, collaborative study, emory university school, emory university school of medicine, honokiol, human cancers, hunter college, kinds of cancer, medicinal chemists, natural compound, phospholipase, target, types of cancers